Bio-Rad Laboratories (BIO) Change in Cash (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Change in Cash data on file, last reported at -$23.2 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 169.67% year-over-year to -$23.2 million in Q1 2026; TTM through Mar 2026 was -$14.1 million, a 115.79% decrease from a year earlier, with the FY2025 full-year figure at $42.4 million, down 50.35% from the prior year.
• Change in Cash for Q1 2026 stood at -$23.2 million, down from $134.0 million in the prior quarter.
• Over the last five years, Change in Cash for BIO reached as high as $331.5 million in Q1 2022 and fell as low as -$205.7 million in Q2 2022.
• Historically, Change in Cash has averaged $2.2 million across 5 years, with a median of $4.5 million in 2024.
• Across the five-year window, Change in Cash soared 3030.82% in 2022 and slumped 480.08% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$83.7 million in 2022, then soared by 35.65% to -$53.9 million in 2023, then surged by 244.05% to $77.6 million in 2024, then soared by 72.68% to $134.0 million in 2025, then tumbled by 117.31% to -$23.2 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$23.2 million in Q1 2026, $134.0 million in Q4 2025, and $26.5 million in Q3 2025.